- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06938620
Efficacy of Flow Restrictors in Limiting Access of Liquid Medicines by Young Children
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Unsupervised ingestion of medications by young children is an important public health concern, leading to tens of thousands of emergency department visits and many more calls to poison control centers each year. Current knowledge on the specific circumstances in which young children gain access to medications is limited; however, a number of studies have shown that improper replacement of child-resistant packaging (CRP) by a caregiver leads to a substantial number of these incidents. Beginning in 2011, several pharmaceutical manufacturers introduced flow restrictors on over-the-counter (OTC) infants' acetaminophen; however, the efficacy of flow restrictors in limiting accessibility of liquid medicines by young children has not been formally assessed.
This study sought to determine whether adding flow restrictors, adapters added to the neck of a bottle to limit the release of liquid, to liquid medicine bottles can provide additional protection against unsupervised medicine ingestions by young children. A modified version of the standard child test protocol for re-closeable packages outlined in the Poison Prevention Packaging Act (PPPA protocol) was used to assess the efficacy of flow restrictors in limiting children's access to liquid medicines. Preschool-aged children participated in two 10-minute trials in which they were asked to try to "get everything out" of bottles filled with test liquid (a food product with similar flow characteristics to liquid medicine). Randomized block design was used to assign specific bottles to participants. Each child tested an uncapped bottle with a flow restrictor (FR-bottle) for one trial (1 of 3 designs randomly assigned). For the other trial, the child tested a control bottle (a traditional bottle either no cap or an incompletely-closed child-resistant cap). The amount of liquid the child removed from each bottle was measured and the time required to empty bottles was recorded. If flow restrictors limit the amount of liquid a young child can access, even when the outer child-resistant cap is not fully secured, their use could potentially be expanded to other liquid medicines.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Attends one of the participating preschools
- Is between 36 - 59 months of age
- Is an English speaker
Exclusion Criteria:
- Has an obvious or overt, temporary or permanent, injury, illness, or physical or mental disability
- Has known allergies/restrictions to ingesting any ingredients in the test liquid
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bottle with a flow restrictor
Bottle with 1 of 3 randomly assigned flow restrictor designs (FR-bottle)
|
Flow restrictors added to liquid medicine bottles to determine whether they limit accessibility of liquid bottle contents to young children compared with control bottles without flow restrictors.
|
|
Active Comparator: Control bottle
Traditional bottle either no cap or an incompletely-closed child-resistant cap
|
Traditional bottle either no cap or an incompletely-closed child-resistant cap
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of children who removed specified amounts of test liquid from FR-bottles compared with control bottles
Time Frame: 0 days
|
Proportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles
|
0 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time required to empty the bottles
Time Frame: 0 days
|
Proportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles
|
0 days
|
|
Proportion of liquid removed from bottles
Time Frame: 0 days
|
Proportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles
|
0 days
|
|
Approaches used to remove liquid from bottles
Time Frame: 0 days
|
Proportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles
|
0 days
|
|
Differences in proportions of children who removed specified amounts of liquid by age, sex, and site
Time Frame: 0 days
|
Proportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles
|
0 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Amount of test liquid removed from individual FR-bottle designs
Time Frame: 0 days
|
Proportion of children who emptied bottles, removed ≥ 25 mL, and who removed ≥ 5 mL of liquid from FR-bottles compared with control bottles
|
0 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Daniel S Budnitz, MD, MPH, Centers for Disease Control and Prevention
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CDC-NCEZID-6162
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Enhanced Child-safety Packaging
-
Cairo UniversityCompletedShort-Term Renal-Hematologic Safety | Contrast-Enhanced MRI and FDG-PET/CT | Spinal PathologyEgypt
-
Phoenix Children's HospitalCompletedChild Passenger SafetyUnited States
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
University of Alabama at BirminghamEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedChild Pedestrian SafetyUnited States
-
The International Livestock Research Institute...CompletedFood Safety | Child NutritionKenya
-
The International Livestock Research Institute...Bill and Melinda Gates Foundation; Department for International Development... and other collaboratorsTerminatedFood Safety | Child NutritionKenya
-
Elizabeth Glaser Pediatric AIDS FoundationAga Khan University; Development Media International; Ministry of Health, Community... and other collaboratorsCompletedChild Development | Knowledge, Attitudes, Practice | Safety Issues | Father-Child RelationsTanzania
-
Minnesota HealthSolutionsChildren's Hospital of Philadelphia; University of Alabama at BirminghamCompleted
-
Medical College of WisconsinCompletedChild Passenger Seat SafetyUnited States
-
University of Wisconsin, MadisonAgency for Healthcare Research and Quality (AHRQ); Pediatric Research in Inpatient...RecruitingMedical Errors | Hospitalized Child | Pediatric Patient Safety | Parental Engagement in Care | Inpatient Pediatric CareUnited States
Clinical Trials on Bottle with a flow restrictor
-
Iladevi Cataract and IOL Research CenterCompleted
-
Centre Hospitalier Intercommunal de Toulon La Seyne...RecruitingAnterior Cruciate Ligament ReconstructionFrance
-
Czech Technical University in PragueUnknown
-
Phenox GmbHRecruitingStenosis | Intracranial Aneurysms | Pseudoaneurysm | Perforation | Saccular and Fusiform Aneurysms | Vascular Dissection | Bifurcation Aneurysms | Neurovascular Abnormalties | Wide-neck AneurysmGermany, Switzerland, France, Slovakia, Italy
-
University Hospital, BordeauxBalt ExtrusionNot yet recruitingRuptured and Unruptured Intracranial AneurysmsFrance
-
George Fox UniversityUnknownMuscle Weakness | Can Blood Flow Restriction Therapy Augments Strength Gains in the Rotator CuffUnited States
-
University of AlcalaWithdrawnSubacromial Pain SyndromeSpain
-
Yakult U.S.A. Inc.Illinois Institute of Technology; Biofortis Clinical Research, Inc.Completed
-
Southeast University, ChinaRecruitingCritical Illness | Mechanical Ventilation Pressure HighChina